Press Releases

Investment Follows Recent $3 Million Whitebox Hedge Fund Investment and $25 Million Equity Facility Agreement With Toucan Partners Bethesda, MD, July 8, 2011 – Northwest Biotherapeutics (OTC Bulletin Board: NWBO) (“NWBT”) announced today a $4.55 million equity investment on June 28, 2011, by The Richard M. Schulze Family Foundation (the “Foundation”). The sale of newly issued common stock of the Company to the... Read More

Northwest Biotherapeutics Announces Change and Expansion of Management Team Bethesda, Maryland, June 8, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) today announced that it has made changes and substantially expanded its management team, adding several highly experienced executives. Ms. Linda Powers, who has served as Chairman of the Board since May 2007, has been appointed Chief Executive Officer. Dr. Anthony Maida, a well known... Read More

$3 Million Initial Funding, and Up To $25 Million Further Funding On Fixed, Favorable Terms Bethesda, Maryland, June 5, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) today announced that it has put in place a series of financing arrangements, including a $3 million investment already received, and access to up to $25 million of further funding on fixed, specified and favorable terms, at such times and in such amounts as the Company... Read More

Addition of Clinical Sites Ahead of Projections Bethesda, Maryland, May 25, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) today announced that it has accelerated the addition of clinical trial sites, exceeding its projections for the doubling of such sites across the U.S. this calendar quarter, for enrollment of new patients into the Company’s ongoing 240-patient randomized, double blind, placebo controlled clinical trial of DCVax®... Read More

Talk will highlight early clinical data, and the phase II clinical trial design Bethesda, Maryland, May 20, 2011 – Northwest Biotherapeutics (OTC Bulletin Board: NWBO) announced today that its Chief Technical Officer, Dr. Marnix Bosch, will give a presentation on “Autologous Dendritic Cells for Glioblastoma” on Saturday, on May 21, at 1:45 pm at the 14thAnnual Meeting of the American Society of Cell and Gene Therapy in Seattle, WA. Dr.... Read More